In 2023, Chugai Pharmaceutical conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Waste Recovered | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Hazardous Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Non-Hazardous Waste Disposed | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.
In 2023, Chugai Pharmaceutical generated a total of 3,527 metric tonnes of waste.
Of this amount, 99.12% of Chugai Pharmaceutical's total waste generated was recovered through methods such as recycling, reuse, or composting, while 0.99% was disposed of through landfilling, incineration, or combustion.
In 2023, Chugai Pharmaceutical reported a total waste generation of 3,527 metric tonnes, of which 99.12% was recovered through recycling, reuse, or composting. This high recovery rate suggests that Chugai Pharmaceutical has implemented strong circular economy practices and actively prioritizes sustainable waste management.
Since 2019, Chugai Pharmaceutical's total waste generation increased by 10.84%, but declined by 14.23% in the year 2023, suggesting a potential shift toward more efficient material use or the early impact of waste reduction strategies.
Over the same period, Chugai Pharmaceutical's waste recovery rate increased by 8.24%, while holding steady in 2023, suggesting past gains in recovery performance have stabilized.
Overall, Chugai Pharmaceutical’s waste generation and recovery data show a mixed and inconsistent trend. A deeper analysis of the company's activities, industry benchmarks, and operational changes is needed to assess its sustainability performance more precisely.
In 2023, Chugai Pharmaceutical generated a total of 3,527 metric tonnes of waste.
Of this amount, 23.11% of Chugai Pharmaceutical's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 76.84% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.
Since 2019, Chugai Pharmaceutical's total waste generation increased by 10.84%, including a 14.23% rise in 2023, reflecting a persistent upward trend that could be linked to operational growth, inefficient material use, or limited investment in waste prevention systems.
Over the same period, Chugai Pharmaceutical reduced the hazardousness of its waste by 9.45%, with a further 15.84% decline in 2023, suggesting a sustained and meaningful shift toward safer waste profiles and lower environmental impact.
Overall, Chugai Pharmaceutical has increased waste over time but is now demonstrating meaningful progress in both reducing waste generation and lowering its hazardous content, potentially signaling a turning point toward sustainability.
In 2023, Chugai Pharmaceutical reported that 815 metric tonnes of its total waste output were classified as hazardous. This represents 23.11% of its overall waste generation.
The company treated this hazardous waste using a combination of methods. A majority (98.65%) was diverted from disposal through recovery-oriented treatments such as recycling or reuse. This suggests that Chugai Pharmaceutical has established processes to reduce the environmental burden of its most harmful waste streams.